Insights from 2023 ASH Annual Meeting
C

ASH 2023 Insights: "Obinutuzumab, Lenalidomide, and Venetoclax in Patients With Treatment-Naïve Advanced Stage Follicular Lymphoma"

By Insights from 2023 ASH Annual Meeting FEATURING Chan Cheah
By Insights from 2023 ASH Annual Meeting FEATURING Chan Cheah
42 views
December 20, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl
27:51
Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
27:49
MyCancerHaven

Overview of the Diagnosis and Treatment of Follicular Lymphoma

Feat. R. Vij, T. Fehniger
15:08
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choic…

Feat. L. Nastoupil
17:19
SOHO Turkey 2023

SOHO Turkey 2023: How I Treat Follicular Lymphoma

Feat. J. Lister
15:11
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Lymphoma Bispecific Antibody Therapy and Management of CRS

Feat. D. Land, M. Hughes
11:12
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: Indolent B-Cell Lymphoma

Feat. L. Nastoupil
09:10
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Acalabrutinib Added to Lenalidomide & R…

Feat. P. Strati
36:10
University of Colorado Division of Hematology

2023 Denver ASH Review: Updates in CLL and Lymphoma

Feat. A. Major
14:36
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

The Latest Data on New Therapies in FL and MZL

Feat. J. Carter
38:55
Indy Hematology Review

Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…

Feat. G. Salles
06:03
Yale Cancer Center

Yale School of Medicine Approach to Lymphadenopathy: Which Patients …

Feat. I. Isufi
17:41
5th SOHO Italy Annual Conference

SOHO Italy 2023: How I Manage Follicular, Marginal Zone and Mantle C…

Feat. S. Luminari
15:32
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Current Clinical Managment of Follicular Lymphoma

Feat. B. Ferhanoğlu
15:53
SOHO Brazil 2023

2023 SOHO® Brazil: "Treating First and Second Line Follicular L…

Feat. J. Alderuccio
22:14
MyCancerHaven

Experts Discuss Highlights in Lymphoma From ASCO® 2023

Feat. R. Vij, D. Russler-Germain
21:17
Yale Cancer Center

ASH 2022 Highlights: Follicular and Indolent NHL

Feat. F. Montanari
20:06
Yale Cancer Center

Managing Suspicious Lymphadenopathy After URI - Malignancy Considera…

Feat. P. Alam, F. Montanari
16:31
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

Advances in Follicular and Marginal Zone Lymphomas

Feat. J. Carter